Amalgamated Bank’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-21,710
| Closed | -$131K | – | 1839 |
|
|
2019
Q4 | $131K | Buy |
21,710
+1,996
| +10% | +$11.6K | ﹤0.01% | 1704 |
|
|
2019
Q3 | $71K | Sell |
19,714
-192
| -1% | -$740 | ﹤0.01% | 1682 |
|
|
2019
Q2 | $53K | Buy |
19,906
+820
| +4% | +$2.42K | ﹤0.01% | 1744 |
|
|
2019
Q1 | $56K | Buy |
19,086
+688
| +4% | +$1.69K | ﹤0.01% | 1642 |
|
|
2018
Q4 | $29K | Hold |
18,398
| – | – | ﹤0.01% | 1600 |
|
|
2018
Q3 | $68K | Buy |
18,398
+128
| +0.7% | +$381 | ﹤0.01% | 1407 |
|
|
2018
Q2 | $52K | Buy |
18,270
+279
| +2% | +$950 | ﹤0.01% | 1699 |
|
|
2018
Q1 | $67K | Buy |
17,991
+2,152
| +14% | +$7.04K | ﹤0.01% | 1552 |
|
|
2017
Q4 | $46K | Buy |
15,839
+1,153
| +8% | +$4.19K | ﹤0.01% | 1618 |
|
|
2017
Q3 | $66K | Buy |
14,686
+276
| +2% | +$1.23K | ﹤0.01% | 1536 |
|
|
2017
Q2 | $66K | Buy |
14,410
+37
| +0.3% | +$149 | ﹤0.01% | 1534 |
|
|
2017
Q1 | $61K | Sell |
14,373
-3
| -0% | -$12 | ﹤0.01% | 1465 |
|
|
2016
Q4 | $59K | Buy |
14,376
+1,982
| +16% | +$10.5K | ﹤0.01% | 1478 |
|
|
2016
Q3 | $100K | Buy |
12,394
+15
| +0.1% | +$128 | 0.01% | 1339 |
|
|
2016
Q2 | $110K | Buy |
12,379
+2
| +0% | +$17 | 0.01% | 1330 |
|
|
2016
Q1 | $96K | Buy |
12,377
+1,105
| +10% | +$8.09K | 0.01% | 1229 |
|
|
2015
Q4 | $122K | Sell |
11,272
-1,098
| -9% | -$9.98K | 0.02% | 1137 |
|
|
2015
Q3 | $85K | Buy |
12,370
+207
| +2% | +$1.69K | 0.01% | 1245 |
|
|
2015
Q2 | $108K | Buy |
+12,163
| New | +$115K | 0.01% | 1299 |
|
|
2014
Q1 | – | Sell |
-10,028
| Closed | -$33K | – | 859 |
|
|
2013
Q4 | $33K | Buy |
+10,028
| New | +$29.1K | 0.01% | 831 |
|
Amalgamated Bank's ACHN Position: Q1 2020 in Review
Amalgamated Bank sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 21,710 shares — an estimated $131K sold.
Amalgamated Bank first reported a position in ACHN in Q4 2013 and held it in 20 quarters. The position peaked at $131K in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- Amalgamated Bank reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- Amalgamated Bank sold 21,710 Achillion Pharmaceuticals shares in Q1 2020, an estimated $131K.
- Amalgamated Bank first reported a position in Achillion Pharmaceuticals in Q4 2013 and held it in 20 quarters.
- Amalgamated Bank's Achillion Pharmaceuticals position peaked at $131K in Q4 2019.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on Amalgamated Bank's 13F filing for Q1 2020, filed 13 May 2020.